InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Glessner Coleen, VP Exécutif. Director active across 1 companies, notably Emergent BioSolutions Inc.. In total, 3 reports have been logged. Total volume traded: €525k. The latest transaction was filed on 7 October 2025 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
US$262,62630,608 shares@ US$8.58030.064% mcap100.0% of flow
Common Stock
SEC:0001919170-25-000004·
€262,62630,608 shares@ €8.58030.064% mcap50.0% of flow
Common Stock
SEC:0001919170-25-000004:0·
05,913 shares0
Common Stock
SEC:0001367644-22-000063:0·
3 of 3 declarations
About Glessner Coleen
Coleen Glessner is the Executive Vice President of Quality and Ethics at Emergent BioSolutions Inc. She oversees the company's quality and ethics initiatives, ensuring compliance and integrity in operations. Her role is crucial for Emergent's reputation.
